MENU

AFMD Affimed NV Forecast, Technical & Fundamental Analysis

a developer of antibody-based therapeutic drugs

Industry Biotechnology
AFMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
AFMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AFMD is expected to report earnings to fall 26.23% to -69 cents per share on March 27

Affimed NV AFMD Stock Earnings Reports
Q4'24
Est.
$-0.69
Q3'24
Missed
by $0.09
Q2'24
Missed
by $0.04
Q1'24
Beat
by $0.28
Q4'23
Beat
by $0.22
The last earnings report on November 14 showed earnings per share of -93 cents, missing the estimate of -85 cents. With 567.13K shares outstanding, the current market capitalization sits at 24.75M.
A.I. Advisor
published General Information

General Information

a developer of antibody-based therapeutic drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Gottlieb-Daimler-Strabe 2
Phone
+49 621560030
Employees
78
Web
https://www.affimed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

AFMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AFMD has been loosely correlated with NTLA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AFMD jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AFMD
1D Price
Change %
AFMD100%
-29.11%
NTLA - AFMD
36%
Loosely correlated
-1.87%
TNYA - AFMD
34%
Loosely correlated
-51.04%
NKTR - AFMD
34%
Loosely correlated
+2.00%
PGEN - AFMD
34%
Loosely correlated
+2.46%
XERS - AFMD
33%
Loosely correlated
+1.19%
More